What Happens When a Medical Device Manufacturer Changes Its Name or Address? CDSCO Regulatory Guide

Changes in a company's name or address are common during business expansion, restructuring, relocation, or administrative updates. However, for medical device manufacturers operating in India, these changes may have regulatory implications beyond updating company records.

Under the Medical Devices Rules, 2017 (MDR 2017), manufacturers and licence holders must assess whether a proposed change affects their existing licence, approved manufacturing site, technical documentation, or quality management system (QMS).

The type of modification determines the regulatory process. Relocating to a new manufacturing location, changing the name of an existing manufacturing site, changing the registered office address, and changing a company's legal constitution are all distinct circumstances that shouldn't be used interchangeably.

CDSCO's Addendum No. 03 to the Medical Devices Rules, 2017 FAQ, dated 3 November 2025, specifically clarifies certain procedures for changes to manufacturing sites and company information. This article explains the key regulatory considerations for medical device manufacturers and outlines how to manage name and address changes while maintaining compliance.

1. Why Is a Change in Manufacturer Name or Address Important?

A manufacturing licence identifies the licence holder and the manufacturing arrangements authorised by the relevant licensing authority. Changes to these details may affect the consistency of the licence, supporting documents, quality records, and product information.

For instance, after engaging in a corporate rebranding initiative, a manufacturer might alter its registered company name. It's possible for another manufacturer to relocate its manufacturing plant. The regulatory obligations may be very different, even if all scenarios include changes to corporate information.

Before implementing a change, manufacturers should establish:

• Whether the legal entity holding the licence remains the same.
• Whether only the company or manufacturing site's name is changing.
• Whether the registered office or correspondence address is changing.
• Whether the physical manufacturing location is changing.
• Whether the company's constitution or ownership structure is changing.
• Whether the proposed change affects approved products, technical documents, labelling, or QMS arrangements.

This initial assessment helps determine the appropriate regulatory pathway and documentation requirements.

2. Change in Manufacturer Name: What Is the Regulatory Impact?

A manufacturer may change its name because of rebranding, a corporate name change, or another legal or administrative development.

The first step is to determine whether the change affects only the name or also changes the legal entity or constitution of the licence holder.

Change in actual manufacturing site name

CDSCO's FAQ Addendum No. 03, dated 3 November 2025, addresses a specific situation: a change in the name of the actual manufacturing site without a change in the constitution of the firm.

According to the clarification, a fresh licence is not required solely for this change. The firm must obtain approval from the licensing authority through the applicable post-approval change (PAC) process. Manufacturers should prepare the supporting evidence needed to establish the updated name and ensure that the existing approved manufacturing arrangements remain accurately represented.

Change in the legal name of the company

A legal company-name change should be assessed separately from a manufacturing-site name change. The appropriate procedure depends on the licence holder's legal status, whether its constitution has changed, and the applicable licensing authority's requirements.

Manufacturers should not assume that a company-name change can automatically be processed through the same procedure as a manufacturing-site name change.

Relevant supporting records may include:

• Updated company registration or incorporation documents.
• Evidence of the approved name change.
• Existing manufacturing licence details.
• Updated company and manufacturing-site information.
• Revised regulatory documents, where applicable.
• A comparison of the previous and proposed particulars.

The final documentation and submission pathway should be confirmed with the relevant licensing authority.

3. Change in Registered Office or Correspondence Address

A company may relocate its registered office or change its correspondence address without moving its manufacturing facility.

This situation should be distinguished from a change in the physical premises where medical devices are manufactured.

CDSCO's FAQ Addendum No. 03 addresses changes to the registered office or correspondence address in the Medical Devices Online System. It states that the applicant may write to the CDSCO Headquarters IT Cell through the Central Registration Unit (CRU) to request the necessary changes in the online system. Manufacturers should verify the current contact details and applicable procedure before submitting a request.

Before proceeding, confirm that:

• The physical manufacturing premises remain unchanged.
• The new address is correctly recorded in company documentation.
• The address update does not conceal an actual relocation of manufacturing operations.
• The appropriate licensing authority has been informed or consulted where required.
• Relevant online records and regulatory correspondence are updated.

An administrative address update should not be used as a substitute for obtaining approval for a manufacturing-site relocation.

4. Change in Manufacturing Site Address: Is a Fresh Licence Required?

A change in the physical location of a manufacturing facility is more significant than a change in its name or correspondence address.

A relocation may affect the facility layout, manufacturing equipment, utilities, environmental controls, personnel arrangements, production processes, testing activities, and quality management system.

For this reason, manufacturers should not assume that an existing manufacturing licence automatically covers a new premises.

CDSCO clarification on relocation within India

CDSCO's FAQ Addendum No. 03 specifically states that a QMS re-inspection or audit is mandatory under the Medical Devices Rules, 2017, when the location of a manufacturing site in India changes. The applicable licensing procedure and whether a fresh manufacturing licence is required must be determined from the relevant rules, current official clarifications, device classification, and licensing authority's requirements.

Manufacturers should assess the proposed relocation before moving production activities.

Key areas to assess before relocation

• Suitability of the new premises for the approved manufacturing activities.
• Availability and qualification of manufacturing and testing equipment.
• Facility layout and environmental controls.
• Personnel and technical supervision arrangements.
• Quality management system documentation.
• Process validation and other required validation activities.
• Storage, traceability, and product-handling arrangements.
• Required inspection, audit, and licensing steps.

Important: A change in the physical manufacturing location should not be treated as a routine address correction. Confirm the applicable regulatory pathway before commencing manufacturing at the new site.

5. Change in Company Constitution or Ownership

A change in company constitution is different from a simple change in the company's name.

Depending on the circumstances, changes involving the legal constitution of the licence holder may require a fresh licensing application or other regulatory action.

Rule 27 of the Medical Devices Rules, 2017, addresses changes in the constitution of a licensee. It establishes requirements for informing the relevant Central or State Licensing Authority and applying for a licence in accordance with the applicable provisions. The regulatory implications depend on the legal structure and the nature of the transaction. A change in constitution should therefore be evaluated before assuming that the existing licence can continue unchanged.

Documents to review

Depending on the circumstances, the manufacturer may need to review:

• Updated incorporation or registration documents.
• Relevant ownership or constitution records.
• Existing licence and approved product details.
• Information about the licence-holding entity.
• Technical personnel and QMS responsibilities.
• Applicable declarations, applications, and supporting documents.

6. What Happens to the Existing Manufacturing Licence?

The effect of a name or address change depends on the nature of the change and the regulatory approval required.

Manufacturers should not assume that every change automatically invalidates an existing licence. Equally, they should not assume that the original licence authorises every proposed change.

The appropriate action may involve:

• Updating company or correspondence information.
• Obtaining approval for a post-approval change.
• Applying for a fresh licence where required.
• Completing the applicable inspection or QMS audit.
• Updating relevant technical and quality documentation.

The manufacturer should establish the correct pathway before implementing the change and maintain records of the licensing authority's decision.

7. Updating DMF, PMF, QMS, and Other Regulatory Documents

Once a change has been assessed, the manufacturer should review all affected documentation to ensure consistency across regulatory and quality records.

The extent of the review depends on whether the change is administrative, legal, or related to the manufacturing premises.

Device Master File (DMF)

Review the Device Master File where the change affects relevant device or manufacturer particulars. Check that the applicable information remains consistent with the approved regulatory documentation.

Plant Master File (PMF)

Review the Plant Master File where the change affects manufacturing-site information, facility layout, equipment, production arrangements, or other relevant facility details.

Quality Management System

The QMS should reflect the manufacturer's actual legal identity, approved manufacturing arrangements, and applicable procedures.

Relevant documents may include:

• Quality manual and controlled procedures.
• Organisation charts and assigned responsibilities.
• Facility and equipment records.
• Supplier and outsourced-process documentation.
• Training and competency records.
• Risk management and validation documentation.
• Change-control records.

Product labelling and instructions for use

Where a manufacturer-name or address change affects product labels, packaging, or instructions for use, the manufacturer should assess the applicable regulatory requirements before introducing revised materials.

All affected documents should be controlled so that obsolete information is not inadvertently used.

8. Recommended Procedure for Managing a Name or Address Change

A structured change-control process helps manufacturers identify regulatory requirements before making the change.

Step 1: Define the proposed change

Document exactly what will change: the legal name, manufacturing-site name, correspondence address, registered office, physical manufacturing location, or company constitution.

Step 2: Conduct a regulatory impact assessment

Review the applicable provisions of the Medical Devices Rules, 2017, relevant CDSCO FAQs and circulars, the existing licence conditions, and the requirements of the licensing authority.

Step 3: Identify the required regulatory action

Determine whether the change requires an online record update, a post-approval change application, notification, fresh licensing application, inspection, or another procedure.

Step 4: Prepare supporting documentation

Collect the relevant company records, licence details, updated site information, and revised technical or quality documents.

Step 5: Submit the required application or request

Use the applicable regulatory route and provide the required supporting evidence. Retain submission acknowledgements and related correspondence.

Step 6: Complete any required assessment or audit

Where an inspection, QMS audit, or further regulatory review is required, coordinate the necessary activities with the relevant authority.

Step 7: Update controlled records

After the appropriate approval or confirmation, update affected licence records, internal procedures, technical files, labels, and other documents as applicable.

Step 8: Verify implementation

Confirm that the final approved details are reflected consistently across the relevant regulatory and quality records.

9. Common Mistakes Manufacturers Should Avoid

• Treating every name or address change in the same way: A company-name change, site-name change, correspondence-address update, and physical relocation may have different requirements.
• Moving production before confirming the regulatory pathway: Relocation can require licensing action and QMS re-inspection or audit.
• Updating internal documents only: Changes to internal records do not replace an approval or application required by the licensing authority.
• Ignoring changes in company constitution: Legal restructuring may have implications beyond updating the name on a licence.
• Using outdated regulatory guidance: Manufacturers should consult the latest applicable rules and official clarifications before proceeding.
• Failing to maintain an audit trail: Retain the change assessment, supporting documents, submissions, approvals, and revised controlled records.

10. Medical Device Manufacturer Name and Address Change Checklist

Use this checklist as an internal planning tool before initiating a change.

• Identify the exact nature of the proposed change.
• Confirm the existing licence holder and licence details.
• Determine whether the legal constitution has changed.
• Establish whether the physical manufacturing location will change.
• Review the relevant CDSCO rules and current official clarifications.
• Determine the applicable notification, application, or approval pathway.
• Prepare supporting company and manufacturing-site documents.
• Assess the impact on DMF, PMF, and QMS documentation.
• Review affected product labels and instructions for use.
• Complete any required inspection, audit, or regulatory review.
• Obtain the required approval or confirmation before implementing changes where applicable.
• Update controlled records and maintain evidence of regulatory compliance.

The exact requirements should be confirmed for the specific licence, device category, and proposed change.

Conclusion

A change in a medical device manufacturer's name or address can have different regulatory consequences depending on whether it involves a legal-name update, a manufacturing-site name change, a correspondence-address update, a change in constitution, or relocation to a new facility.

Under the Medical Devices Rules, 2017, manufacturers should evaluate the proposed change carefully, follow the applicable CDSCO or State Licensing Authority procedure, and ensure that their regulatory and quality documentation remains accurate.

The most effective approach is to assess the change before implementation, identify the required approval or notification, and maintain a complete record of the regulatory decision.

Need Assistance With CDSCO Name or Address Changes?

MDR Consultants supports medical device manufacturers with CDSCO licensing, post-approval changes, regulatory documentation, DMF and PMF updates, QMS support, and ongoing compliance requirements.

Contact MDR Consultants to discuss your proposed manufacturer-name or address change and identify the appropriate regulatory pathway for your situation.

Last Updated : 13 Oct 2026